Tech Company Financing Transactions
Efficas Funding Round
On 1/4/2005, Efficas raised $3 million in Series A funding from JPMorgan Partners.
Transaction Overview
Company Name
Announced On
1/4/2005
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Investors
Proceeds Purpose
The A3 round investment funds will be used for development and commercialization of Efficas' pipeline of clinically proven nutritional bioactives and to broaden its partner infrastructure for rapid delivery of its products into the marketplace.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
310 N Harbor Blvd. 205
Fullerton, CA 92832
USA
Fullerton, CA 92832
USA
Phone
Website
Email Address
Overview
Efficas is a consumer focused health-science and technology company committed to developing effective products for the nutritional management of the immune system for both humans and pets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Braman
VP - Operations
Robert Driver
Browse more venture capital transactions:
Prev: 1/4/2005: Nereus Pharmaceuticals venture capital transaction
Next: 1/4/2005: XMPie venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. All VC database entries reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs